The Nlrp3 inflammasome regulates acute graft-versus-host disease

Journal of Experimental Medicine

Volumn 210, Issue 10, 2013, Pages 1899-1910

  Jankovic, Dragana ^a   Ganesan, Jayanthi ^b,c   Bscheider, Michael ^d   Stickel, Natalie ^b,c   Weber, Felix C ^b   Guarda, Greta ^e   Follo, Marie ^b   Pfeifer, Dietmar ^b   Tardivel, Aubry ^e   Ludigs, Kristina ^e   Bouazzaoui, Abdellatif ^f   Kerl, Katrin ^a   Fischer, Julius C ^d   Haas, Tobias ^d   Schmitt Gräff, Annette ^b   Manoharan, Anand ^e   Müller, Leonard ^b   Finke, Jürgen ^b   Martin, Stefan F ^b   Gorka, Oliver ^d   Peschel, Christian ^d   Ruland, Jürgen ^d   Idzko, Marco ^b   Duyster, Justus ^b   Holler, Ernst ^f   French, Lars E ^a   Poeck, Hendrik ^d   Contassot, Emmanuel ^a   Zeiser, Robert ^b,c   more..

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; URIC ACID;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL FLORA; COMMENSAL; CYTOKINE PRODUCTION; DENDRITIC CELL; HISTOPATHOLOGY; HUMAN; INTESTINE CELL; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH17 CELL;

ACUTE DISEASE; ANIMALS; CARRIER PROTEINS; CASPASE 1; CYTOSKELETAL PROTEINS; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMASOMES; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTESTINES; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES; TH17 CELLS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTORS;

EID: 84885447590     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130084     Document Type: Article

References (30)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. http://www.nature.com/nri/journal/v4/n7/full/nri1391.html
2. Beelen, D.W., A. Elmaagacli, K.D. Müller, H. Hirche, and U.W. Schaefer. 1999. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graftversus- host disease after marrow traxnsplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood. 93:3267-3275.
3. Bryson, J.S., L. Zhang, S.W. Goes, C.D. Jennings, B.E. Caywood, S.L. Carlson, and A.M. Kaplan. 2004. CD4+ T cells mediate murine syngeneic graft-versus-host disease-associated colitis. J. Immunol. 172: 679-687.
4. Coccia, M., O.J. Harrison, C. Schiering, M.J. Asquith, B. Becher, F. Powrie, and K.J. Maloy. 2012. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J. Exp. Med. 209:1595-1609. http://dx.doi.org/10.1084/jem.20111453
5. Davis, B.K., H. Wen, and J.P. Ting. 2011. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29:707-735. http://dx.doi.org/10.1146/annurev-immunol-031210-101405
6. Drexler, S.K., L. Bonsignore, M. Masin, A. Tardivel, R. Jackstadt, H. Hermeking, P. Schneider, O. Gross, J. Tschopp, and A.S. Yazdi. 2012. Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc. Natl. Acad. Sci. USA. 109:18384-18389. http://dx.doi.org/10.1073/pnas.1209171109
7. Ferrara, J.L., J.E. Levine, P. Reddy, and E. Holler. 2009. Graft-versus-host disease. Lancet. 373:1550-1561. http://dx.doi.org/10.1016/S0140-6736(09)60237-3
8. Ferrari, D., C. Pizzirani, E. Adinolfi, R.M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176:3877-3883.
9. Franchi, L., and G. Núñez. 2012. Immunology. Orchestrating inflammasomes. Science. 337:1299-1300. http://dx.doi.org/10.1126/science.1229010
10. Fulton, L.M., M.J. Carlson, J.M. Coghill, L.E. Ott, M.L. West, A. Panoskaltsis-Mortari, D.R. Littman, B.R. Blazar, and J.S. Serody. 2012. Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt. J. Immunol. 189:1765-1772. http://dx.doi.org/10.4049/jimmunol.1200858
11. Gasse, P., N. Riteau, S. Charron, S. Girre, L. Fick, V. Pétrilli, J. Tschopp, V. Lagente, V.F. Quesniaux, B. Ryffel, and I. Couillin. 2009. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 179:903-913. http://dx.doi.org/10.1164/rccm.200808-1274OC
12. Holler, E., K. Landfried, J. Meier, M. Hausmann, and G. Rogler. 2010. The role of bacteria and pattern recognition receptors in GVHD. Int. J. Inflamm. 2010:814326.
13. Jacobsohn, D.A., and G.B. Vogelsang. 2007. Acute graft versus host disease. Orphanet J. Rare Dis. 2:35-37. http://dx.doi.org/10.1186/1750-1172-2-35
14. Kaplan, D.H., B.E. Anderson, J.M. McNiff, D. Jain, M.J. Shlomchik, and W.D. Shlomchik. 2004. Target antigens determine graft-versus-host disease phenotype. J. Immunol. 173:5467-5475.
15. Kappel, L.W., G.L. Goldberg, C.G. King, D.Y. Suh, O.M. Smith, C. Ligh, A.M. Holland, J. Grubin, N.M. Mark, C. Liu, et al. 2009. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood. 113:945-952. http://dx.doi.org/10.1182/blood-2008-08-172155
16. Kool, M., T. Soullié, M. van Nimwegen, M.A. Willart, F. Muskens, S. Jung, H.C. Hoogsteden, H. Hammad, and B.N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205:869-882. http://dx.doi.org/10.1084/jem.20071087
17. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 440:237-241. http://dx.doi.org/10.1038/nature04516
18. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27:229-265. http://dx.doi.org/10.1146/annurev.immunol.021908.132715
19. Pasquini, M.C., and Z. Wang. (2012). "Current use and outcome of hematopoietic stem cell transplantation." CIBMTR Summary Slides 1: http://www.cibmtr.org.
20. Ram, R., A. Gafter-Gvili, M. Yeshurun, M. Paul, P. Raanani, and O. Shpilberg. 2009. Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplant. 43:643-653. http://dx.doi.org/10.1038/bmt.2008.373
21. Rampello, E., T. Fricia, and M. Malaguarnera. 2006. The management of tumor lysis syndrome. Nat. Clin. Pract. Oncol. 3:438-447. http://dx.doi.org/10.1038/ncponc0581
22. Reichardt, W., C. Dürr, D. von Elverfeldt, E. Jüttner, U.V. Gerlach, M. Yamada, B. Smith, R.S. Negrin, and R. Zeiser. 2008. Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J. Immunol. 181: 4770-4779.
23. Sadeghi, B., N. Aghdami, Z. Hassan, M. Forouzanfar, B. Rozell, M. Abedi-Valugerdi, and M. Hassan. 2008. GVHD after chemotherapy conditioning in allogeneic transplanted mice. Bone Marrow Transplant. 42:807-818. http://dx.doi.org/10.1038/bmt.2008.261
24. Shlomchik, W.D. 2007. Graft-versus-host disease. Nat. Rev. Immunol. 7:340-352. http://dx.doi.org/10.1038/nri2000
25. Turner, B.E., M.E. Kambouris, L. Sinfield, J. Lange, A.M. Burns, R. Lourie, K. Atkinson, D.N. Hart, D.J. Munster, and A.M. Rice. 2008. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Transplantation. 86:968-976. http://dx.doi.org/10.1097/TP.0b013e3181874787
26. Wilhelm, K., J. Ganesan, T. Müller, C. Dürr, M. Grimm, A. Beilhack, C.D. Krempl, S. Sorichter, U.V. Gerlach, E. Jüttner, et al. 2010. Graftversus-host disease enhanced by extracellular adenosine triphosphate activating P2X7R. Nat. Med. 12:1434-1438. http://dx.doi.org/10.1038/nm.2242
27. Yu, Y., D. Wang, C. Liu, K. Kaosaard, K. Semple, C. Anasetti, and X.Z. Yu. 2011. Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice. Blood. 118:5011-5020. http://dx.doi.org/10.1182/blood-2011-03-340315
28. Zeiser, R., V.H. Nguyen, A. Beilhack, M. Buess, S. Schulz, J. Baker, C.H. Contag, and R.S. Negrin. 2006. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood. 108:390-399. http://dx.doi.org/10.1182/blood-2006-01-0329
29. Zeiser, R., S. Youssef, J. Baker, N. Kambhan, L. Steinman, and R.S. Negrin. 2007. Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Blood. 110:4588-4598. http://dx.doi.org/10.1182/blood-2007-08-106005
30. Zeiser, R., D.B. Leveson-Gower, E.A. Zambricki, N. Kambham, A. Beilhack, J. Loh, J.Z. Hou, and R.S. Negrin. 2008. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood. 111:453-462. http://dx.doi.org/10.1182/blood-2007-06-094482